Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Short-lived AUF1 p42-binding mRNAs of RANKL and BCL6 have two distinct instability elements each.

Dogar AM, Pauchard-Batschulat R, Grisoni-Neupert B, Richman L, Paillusson A, Pradervand S, Hagenbüchle O, Ambrosini G, Schmid CD, Bucher P, Kühn LC.

PLoS One. 2018 Nov 12;13(11):e0206823. doi: 10.1371/journal.pone.0206823. eCollection 2018.

PMID:
30418981
2.

Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma.

Bajor DL, Mick R, Riese MJ, Huang AC, Sullivan B, Richman LP, Torigian DA, George SM, Stelekati E, Chen F, Melenhorst JJ, Lacey SF, Xu X, Wherry EJ, Gangadhar TC, Amaravadi RK, Schuchter LM, Vonderheide RH.

Oncoimmunology. 2018 Aug 20;7(10):e1468956. doi: 10.1080/2162402X.2018.1468956. eCollection 2018.

3.

Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice.

Rothwell WT, Bell P, Richman LK, Limberis MP, Tretiakova AP, Li M, Wilson JM.

Cancer Res. 2018 Nov 1;78(21):6171-6182. doi: 10.1158/0008-5472.CAN-18-0363. Epub 2018 Aug 28.

PMID:
30154145
4.

Necessary considerations for a life course perspective on discrimination and health.

Richman LS, Stock M.

Soc Sci Med. 2018 Oct;215:163-166. doi: 10.1016/j.socscimed.2018.08.005. Epub 2018 Aug 18. No abstract available.

PMID:
30150006
5.

Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome.

Greig JA, Nordin JML, Draper C, McMenamin D, Chroscinski EA, Bell P, Gray JT, Richman LK, Wilson JM.

Mol Ther Methods Clin Dev. 2018 Jul 21;10:237-244. doi: 10.1016/j.omtm.2018.07.008. eCollection 2018 Sep 21.

6.

Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques.

Hordeaux J, Hinderer C, Goode T, Katz N, Buza EL, Bell P, Calcedo R, Richman LK, Wilson JM.

Mol Ther Methods Clin Dev. 2018 Jul 14;10:79-88. doi: 10.1016/j.omtm.2018.06.003. eCollection 2018 Sep 21.

7.

Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques.

Hordeaux J, Hinderer C, Goode T, Buza EL, Bell P, Calcedo R, Richman LK, Wilson JM.

Mol Ther Methods Clin Dev. 2018 Jul 14;10:68-78. doi: 10.1016/j.omtm.2018.06.004. eCollection 2018 Sep 21.

8.

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.

Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, Gordon N, Norgard RJ, Yuan S, Yu S, Chao T, Ye S, Eisinger-Mathason TSK, Faryabi RB, Tobias JW, Lowe SW, Coussens LM, Wherry EJ, Vonderheide RH, Stanger BZ.

Immunity. 2018 Jul 17;49(1):178-193.e7. doi: 10.1016/j.immuni.2018.06.006. Epub 2018 Jun 26.

PMID:
29958801
9.

Repairing the Leaky Pipeline: A Motivationally Supportive Intervention to Enhance Persistence in Undergraduate Science Pathways.

Linnenbrink-Garcia L, Perez T, Barger MM, Wormington SV, Godin E, Snyder KE, Robinson K, Sarkar A, Richman LS, Schwartz-Bloom R.

Contemp Educ Psychol. 2018 Apr;53:181-195. doi: 10.1016/j.cedpsych.2018.03.001. Epub 2018 Mar 2.

PMID:
29861537
10.

Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.

Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, Richman LK, Wilson JM.

Hum Gene Ther. 2018 Mar;29(3):285-298. doi: 10.1089/hum.2018.015. Epub 2018 Feb 12.

PMID:
29378426
11.

Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.

Huffman AP, Richman LP, Crisalli L, Ganetsky A, Porter DL, Vonderheide RH, Reshef R.

Biol Blood Marrow Transplant. 2018 Mar;24(3):594-599. doi: 10.1016/j.bbmt.2017.10.028. Epub 2017 Oct 20.

PMID:
29061535
12.

Racial (vs. self) affirmation as a protective mechanism against the effects of racial exclusion on negative affect and substance use vulnerability among black young adults.

Stock ML, Gibbons FX, Beekman JB, Williams KD, Richman LS, Gerrard M.

J Behav Med. 2018 Apr;41(2):195-207. doi: 10.1007/s10865-017-9882-7. Epub 2017 Sep 13.

PMID:
28905204
13.

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.

Moy RH, Huffman AP, Richman LP, Crisalli L, Wang XK, Hoxie JA, Mick R, Emerson SG, Zhang Y, Vonderheide RH, Porter DL, Reshef R.

Blood. 2017 Feb 16;129(7):906-916. doi: 10.1182/blood-2016-08-735076. Epub 2017 Jan 5.

14.

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis.

Lefebvre E, Moyle G, Reshef R, Richman LP, Thompson M, Hong F, Chou HL, Hashiguchi T, Plato C, Poulin D, Richards T, Yoneyama H, Jenkins H, Wolfgang G, Friedman SL.

PLoS One. 2016 Jun 27;11(6):e0158156. doi: 10.1371/journal.pone.0158156. eCollection 2016.

15.

Reading Achievement in Boys With Non-Syndromic Cleft Palate Only: Relationship to Neuropsychological Skill and Neurocircuitry.

Conrad AL, Richman L, Nopoulos P.

Dev Neuropsychol. 2015;40(7-8):395-406. doi: 10.1080/87565641.2016.1142991. Epub 2016 Mar 2.

16.

Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.

Hexner EO, Luger SM, Reshef R, Jeschke GR, Mangan JK, Frey NV, Frank DM, Richman LP, Vonderheide RH, Aqui NA, Rosenbach M, Zhang Y, Chew A, Loren AW, Stadtmauer EA, Levine BL, June CH, Emerson SG, Porter DL.

Am J Hematol. 2016 May;91(5):453-60. doi: 10.1002/ajh.24303. Epub 2016 Apr 4.

17.

Detection of Quiescent Infections with Multiple Elephant Endotheliotropic Herpesviruses (EEHVs), Including EEHV2, EEHV3, EEHV6, and EEHV7, within Lymphoid Lung Nodules or Lung and Spleen Tissue Samples from Five Asymptomatic Adult African Elephants.

Zong JC, Heaggans SY, Long SY, Latimer EM, Nofs SA, Bronson E, Casares M, Fouraker MD, Pearson VR, Richman LK, Hayward GS.

J Virol. 2015 Dec 30;90(6):3028-43. doi: 10.1128/JVI.02936-15.

18.

A Pharmacology-Based Enrichment Program for Undergraduates Promotes Interest in Science.

Godin EA, Wormington SV, Perez T, Barger MM, Snyder KE, Richman LS, Schwartz-Bloom R, Linnenbrink-Garcia L.

CBE Life Sci Educ. 2015 Winter;14(4):ar40. doi: 10.1187/cbe.15-02-0043.

19.

Heteronormativity and practitioner-patient interaction.

Utamsingh PD, Richman LS, Martin JL, Lattanner MR, Chaikind JR.

Health Commun. 2016;31(5):566-74. doi: 10.1080/10410236.2014.979975. Epub 2015 Sep 30.

PMID:
26421354
20.

Validation of the Food-Linked Virtual Response task.

Pascoe EA, Richman LS, Kort D.

J Health Psychol. 2017 Jan;22(1):111-119. doi: 10.1177/1359105315595452. Epub 2016 Jul 10.

PMID:
26227496
21.

Artificial Lithium Toxicity: A Case Report and Review of the Literature.

Richman LS, Dzierba AL, Connolly KA, Bryan PM, Chandra S.

J Pharm Pract. 2015 Oct;28(5):479-81. doi: 10.1177/0897190015587698. Epub 2015 Jun 13. Review.

PMID:
26072429
22.

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.

Reshef R, Huffman AP, Gao A, Luskin MR, Frey NV, Gill SI, Hexner EO, Kambayashi T, Loren AW, Luger SM, Mangan JK, Nasta SD, Richman LP, Sell M, Stadtmauer EA, Vonderheide RH, Mick R, Porter DL.

J Clin Oncol. 2015 Jul 20;33(21):2392-8. doi: 10.1200/JCO.2014.60.1203. Epub 2015 Jun 8.

23.

MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.

Pan W, Zhu S, Dai D, Liu Z, Li D, Li B, Gagliani N, Zheng Y, Tang Y, Weirauch MT, Chen X, Zhu W, Wang Y, Chen B, Qian Y, Chen Y, Fang J, Herbst R, Richman L, Jallal B, Harley JB, Flavell RA, Yao Y, Shen N.

Nat Commun. 2015 May 12;6:7096. doi: 10.1038/ncomms8096.

PMID:
25963922
24.

NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT.

Karimi MA, Bryson JL, Richman LP, Fesnak AD, Leichner TM, Satake A, Vonderheide RH, Raulet DH, Reshef R, Kambayashi T.

Blood. 2015 Jun 4;125(23):3655-63. doi: 10.1182/blood-2015-02-629006. Epub 2015 Mar 18.

25.

Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice.

Baratono SR, Chu N, Richman LP, Behrens EM.

Eur J Immunol. 2015 May;45(5):1313-25. doi: 10.1002/eji.201445319. Epub 2015 Feb 26.

26.

Experimental Evidence That Low Social Status is Most Toxic to Well-being When Internalized.

Jackson B, Richman LS, LaBelle O, Lempereur MS, Twenge JM.

Self Identity. 2015 Mar 1;14(2):157-172.

27.

CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.

Oberst MD, Fuhrmann S, Mulgrew K, Amann M, Cheng L, Lutterbuese P, Richman L, Coats S, Baeuerle PA, Hammond SA.

MAbs. 2014;6(6):1571-84. doi: 10.4161/19420862.2014.975660.

28.

Non-normal random effects models for immunogenicity assay cut point determination.

Zhang J, Yu B, Zhang L, Roskos L, Richman L, Yang H.

J Biopharm Stat. 2015;25(2):295-306. doi: 10.1080/10543406.2014.972515.

PMID:
25356500
29.

Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma.

Bajor DL, Xu X, Torigian DA, Mick R, Garcia LR, Richman LP, Desmarais C, Nathanson KL, Schuchter LM, Kalos M, Vonderheide RH.

Cancer Immunol Res. 2014 Nov;2(11):1051-8. doi: 10.1158/2326-6066.CIR-14-0154. Epub 2014 Sep 24.

30.

Comparative genome analysis of four elephant endotheliotropic herpesviruses, EEHV3, EEHV4, EEHV5, and EEHV6, from cases of hemorrhagic disease or viremia.

Zong JC, Latimer EM, Long SY, Richman LK, Heaggans SY, Hayward GS.

J Virol. 2014 Dec;88(23):13547-69. doi: 10.1128/JVI.01675-14. Epub 2014 Sep 17.

31.

Elephant endotheliotropic herpesviruses EEHV1A, EEHV1B, and EEHV2 from cases of hemorrhagic disease are highly diverged from other mammalian herpesviruses and may form a new subfamily.

Richman LK, Zong JC, Latimer EM, Lock J, Fleischer RC, Heaggans SY, Hayward GS.

J Virol. 2014 Dec;88(23):13523-46. doi: 10.1128/JVI.01673-14. Epub 2014 Sep 17.

32.

Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking.

Richman LP, Vonderheide RH.

Oncoimmunology. 2014 Apr 29;3:e28610. eCollection 2014.

33.

An online daily diary study of alcohol use using Amazon's Mechanical Turk.

Boynton MH, Richman LS.

Drug Alcohol Rev. 2014 Jul;33(4):456-61. doi: 10.1111/dar.12163. Epub 2014 Jun 3.

34.

Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies.

Georgantas RW, Streicher K, Greenberg SA, Greenlees LM, Zhu W, Brohawn PZ, Higgs BW, Czapiga M, Morehouse CA, Amato A, Richman L, Jallal B, Yao Y, Ranade K.

Arthritis Rheumatol. 2014 Apr;66(4):1022-33. doi: 10.1002/art.38292.

35.

The relationship between brain structure and cognition in transfused preterm children at school age.

McCoy TE, Conrad AL, Richman LC, Brumbaugh JE, Magnotta VA, Bell EF, Nopoulos PC.

Dev Neuropsychol. 2014;39(3):226-32. doi: 10.1080/87565641.2013.874428.

36.

Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations.

Vanoaica L, Richman L, Jaworski M, Darshan D, Luther SA, Kühn LC.

PLoS One. 2014 Feb 21;9(2):e89270. doi: 10.1371/journal.pone.0089270. eCollection 2014.

37.

Self-regulatory processes underlying structural stigma and health.

Richman LS, Lattanner MR.

Soc Sci Med. 2014 Feb;103:94-100. doi: 10.1016/j.socscimed.2013.12.029. Review.

PMID:
24507915
38.

The plasma cell signature in autoimmune disease.

Streicher K, Morehouse CA, Groves CJ, Rajan B, Pilataxi F, Lehmann KP, Brohawn PZ, Higgs BW, McKeever K, Greenberg SA, Fiorentino D, Richman LK, Jallal B, Herbst R, Yao Y, Ranade K.

Arthritis Rheumatol. 2014 Jan;66(1):173-84. doi: 10.1002/art.38194.

39.

Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancer.

Richman LP, Vonderheide RH.

Cancer Immunol Res. 2014 Jan;2(1):19-26. doi: 10.1158/2326-6066.CIR-13-0152.

40.

Discrimination hurts, but mindfulness may help: Trait mindfulness moderates the relationship between perceived discrimination and depressive symptoms.

Brown-Iannuzzi JL, Adair KC, Payne BK, Richman LS, Fredrickson BL.

Pers Individ Dif. 2014 Jan;56. doi: 10.1016/j.paid.2013.09.015.

41.

MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.

Georgantas RW 3rd, Streicher K, Luo X, Greenlees L, Zhu W, Liu Z, Brohawn P, Morehouse C, Higgs BW, Richman L, Jallal B, Yao Y, Ranade K.

Pigment Cell Melanoma Res. 2014 Mar;27(2):275-86. doi: 10.1111/pcmr.12200. Epub 2014 Jan 17.

PMID:
24289491
42.

Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.

Mueller C, Chulay JD, Trapnell BC, Humphries M, Carey B, Sandhaus RA, McElvaney NG, Messina L, Tang Q, Rouhani FN, Campbell-Thompson M, Fu AD, Yachnis A, Knop DR, Ye GJ, Brantly M, Calcedo R, Somanathan S, Richman LP, Vonderheide RH, Hulme MA, Brusko TM, Wilson JM, Flotte TR.

J Clin Invest. 2013 Dec;123(12):5310-8. doi: 10.1172/JCI70314. Epub 2013 Nov 15.

43.

Reading in subjects with an oral cleft: speech, hearing and neuropsychological skills.

Conrad AL, McCoy TE, DeVolder I, Richman LC, Nopoulos P.

Neuropsychology. 2014 May;28(3):415-22. doi: 10.1037/neu0000024. Epub 2013 Nov 4.

44.

Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study.

Bao H, Burke PA, Huang J, Chen X, Brohawn PZ, Yao Y, Lechleider RJ, Sikorski RS, Buzoianu M, Zhang J, Shi X, Richman LK, Lavallee TM.

PLoS One. 2013 Aug 21;8(8):e58557. doi: 10.1371/journal.pone.0058557. eCollection 2013.

45.

Polybrominated diphenyl ethers in sediment and caged mussels (Elliptio complanata) deployed in the Niagara River.

Richman LA, Kolic T, Macpherson K, Fayez L, Reiner E.

Chemosphere. 2013 Aug;92(7):778-86. doi: 10.1016/j.chemosphere.2013.04.011. Epub 2013 May 4.

PMID:
23648331
46.

Fatal herpesvirus hemorrhagic disease in wild and orphan asian elephants in southern India.

Zachariah A, Zong JC, Long SY, Latimer EM, Heaggans SY, Richman LK, Hayward GS.

J Wildl Dis. 2013 Apr;49(2):381-93. doi: 10.7589/2012-07-193.

47.

Pharmacogenomics and translational simulations to bridge indications for an anti-interferon-α receptor antibody.

Wang B, Higgs BW, Chang L, Vainshtein I, Liu Z, Streicher K, Liang M, White WI, Yoo S, Richman L, Jallal B, Roskos L, Yao Y.

Clin Pharmacol Ther. 2013 Jun;93(6):483-92. doi: 10.1038/clpt.2013.35. Epub 2013 Feb 14.

PMID:
23511714
48.

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.

Higgs BW, Zhu W, Morehouse C, White WI, Brohawn P, Guo X, Rebelatto M, Le C, Amato A, Fiorentino D, Greenberg SA, Drappa J, Richman L, Greth W, Jallal B, Yao Y.

Ann Rheum Dis. 2014 Jan;73(1):256-62. doi: 10.1136/annrheumdis-2012-202794. Epub 2013 Feb 23.

49.

Estimates of the pharmacokinetics of famciclovir and its active metabolite penciclovir in young Asian elephants (Elephas maximus).

Brock AP, Isaza R, Hunter RP, Richman LK, Montali RJ, Schmitt DL, Koch DE, Lindsay WA.

Am J Vet Res. 2012 Dec;73(12):1996-2000. doi: 10.2460/ajvr.73.12.1996.

50.

Genomic signatures characterize leukocyte infiltration in myositis muscles.

Zhu W, Streicher K, Shen N, Higgs BW, Morehouse C, Greenlees L, Amato AA, Ranade K, Richman L, Fiorentino D, Jallal B, Greenberg SA, Yao Y.

BMC Med Genomics. 2012 Nov 21;5:53. doi: 10.1186/1755-8794-5-53.

Supplemental Content

Loading ...
Support Center